Dr. Nora Volkow, director of the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, will join President Bill Clinton, New York dignitaries, and college students from New York University for a panel discussion on prescription drug abuse. The panel will address prescription drug abuse, particularly among 18 - 26 year olds, and how the Clinton Foundation's Clinton Health Matters Initiative can work with others to contribute to solutions in New York and nationwide.
WHAT: Prescription Drug Abuse: A Forum with President Clinton, Commissioner Ray Kelly, NYU President John Sexton, and Dr. Nora Volkow
Hosted by the Clinton Foundation's Clinton Health Matters Initiative
WHEN: Monday, May 6, 2013
10:30 a.m. EST
(Press must check in by 9:45 a.m. EST)
WHERE: New York University School of Law
Vanderbilt Hall, Greenberg Lounge
40 Washington Square South
New York, N.Y. 10012
Media interested in attending must RSVP by May 5 to email@example.com.
WHO: Featured Speakers
President Bill Clinton
Founder, Clinton Foundation
42nd President of the United States
Raymond W. Kelly
Police Commissioner, City of New York
John Sexton, Ph.D., J.D.
President, New York University
Nora D. Volkow, M.D.
Director, National Institute on Drug Abuse
For more information on prescription drug misuse, visit: http://www.
The National Institute on Drug Abuse is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world's research on the health aspects of drug abuse and addiction. The Institute carries out a large variety of programs to inform policy and improve practice. Fact sheets on the health effects of drugs of abuse and information on NIDA research and other activities can be found on the NIDA home page at http://www.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.